|
|
||||||||



*
Institute of Cancer Research and Molecular Biology, Norwegian University of Science and Technology, Trondheim, Norway;
Instituto di Microbiologia, Facolta di Medicina e Chirurgia, Universita degli Studi di Messina, Messina, Italy; and
Department of Medicine, Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center and Boston University School of Medicine, Boston, MA 02118
Human Toll like receptor (TLR) 2 has been implicated as a signaling
receptor for LPS from Gram-negative bacteria and cell wall components
from Gram-positive organisms. In this study, we investigated whether
TLR2 can signal cell activation by the heat-killed group B streptococci
type III (GBS) and Listeria monocytogenes (HKLM). HKLM,
but not GBS, showed a time- and dose-dependent activation of Chinese
hamster ovary cells transfected with human TLR2, as measured by
translocation of NF-
B and induction of IL-6 production. A mAb
recognizing a TLR2-associated epitope (TL2.1) was generated that
inhibited IL-6 production from Chinese hamster ovary-TLR2 cells
stimulated with HKLM or LPS. The TL2.1 mAb reduced HKLM-induced TNF
production from human monocytes by 60%, whereas a CD14 mAb (3C10)
reduced the TNF production by 30%. However, coadministrating TL2.1 and
3C10 inhibited the TNF response by 80%. In contrast to this,
anti-CD14 blocked LPS-induced TNF production from monocytes,
whereas anti-TLR2 showed no inhibition. Neither TL2.1 nor 3C10
affected GBS-induced TNF production. These results show that TLR2 can
function as a signaling receptor for HKLM, possibly together with CD14,
but that TLR2 is unlikely to be involved in cell activation by GBS.
Furthermore, although LPS can activate transfected cell lines through
TLR2, this receptor does not seem to be the main transducer of LPS
activation of human monocytes. Thus, our data demonstrate the ability
of TLR2 to distinguish between different
pathogens.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |